22157.jpg
Global Allogeneic Cell Therapy Pipeline Report 2024: Clinical Progress, Treatment Efficacy, and Commercial Potential
April 23, 2024 09:53 ET | Research and Markets
Dublin, April 23, 2024 (GLOBE NEWSWIRE) -- The "Allogeneic Cell Therapies - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering Allogeneic cell therapies represent...
22157.jpg
Natural Killer (NK) Cell Therapy Pipeline Research Report 2024: Comprehensive Insights About 100+ Companies and 185+ Pipeline Drugs
April 19, 2024 07:35 ET | Research and Markets
Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "Natural Killer (NK) cell therapy - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Natural Killer...
22157.jpg
T Cell Therapy Pipeline Insight Report 2024
April 18, 2024 11:34 ET | Research and Markets
Dublin, April 18, 2024 (GLOBE NEWSWIRE) -- The "T cell therapy - Pipeline Insight, 2024" has been added to ResearchAndMarkets.com's offering.The report covers comprehensive insights of present...
Turnstone Logo.jpg
Turnstone Biologics Appoints William Waddill to its Board of Directors
April 16, 2024 09:00 ET | Turnstone Biologics Corp.
Turnstone Biologics appoints biotechnology industry veteran, William Waddill, to its Board of Directors.
Kincell_logo.jpg
Imugene and Kincell Bio Announce Strategic Manufacturing and Process Development Partnership
April 16, 2024 07:00 ET | Kincell Bio
Kincell Bio to acquire Imugene’s North Carolina manufacturing facility for up to $6M USD in upfront and milestone-driven payments over three yearsKincell will expand its capacity and commitment to...
logo-header-min.png
Principal Investigator from City of Hope National Medical Center Invited to Present Clinical Data from Marker Therapeutics APOLLO Study at 11th Global Summit on Hematologic Malignancies 
April 08, 2024 07:00 ET | Marker Therapeutics
Preliminary data from study in patients with lymphoma enrolled at City of Hope National Medical Center was presented at the 11th Global Summit on Hematologic Malignancies in Whistler, BC, Canada ...
outpace logo.png
Outpace Bio Announces Multiple Presentations at the 2024 American Association of Cancer Research (AACR) Annual Meeting
April 04, 2024 07:00 ET | Outpace Bio
Seattle, WA, April 04, 2024 (GLOBE NEWSWIRE) -- Outpace Bio, a cell therapy company that is solving the major barriers to curing solid tumors with unrivaled AI-powered protein design, today...
Global Regenerative Medicine Market
Global Regenerative Medicine Industry Research 2023-2028: Market Driven by Wide Scope in New Therapeutic Areas and Collaborations and Partnerships
April 03, 2024 09:43 ET | Research and Markets
Dublin, April 03, 2024 (GLOBE NEWSWIRE) -- The "Global Regenerative Medicine Market by Product (Stem Cell [Autologous, Allogenic], Immunotherapy, Gene Therapy, Tissue Engineering), Application...
22157.jpg
Global Cell and Gene Therapy Markets Report 2024-2028 Featuring Main Players - Mallinckrodt, Vericel, Gilead Sciences, Pharmicell, and Bristol-Myers Squibb
April 03, 2024 03:10 ET | Research and Markets
Dublin, April 03, 2024 (GLOBE NEWSWIRE) -- The "Global Cell and Gene Therapy Market" report has been added to ResearchAndMarkets.com's offering. The Global Cell and Gene Therapy Market is...
Global Cell Therapy Raw Materials Market
Global Cell Therapy Raw Materials Market Expected to Reach USD 48.04 Billion by 2034
April 02, 2024 12:55 ET | Research and Markets
Dublin, April 02, 2024 (GLOBE NEWSWIRE) -- The "Global Cell Therapy Raw Materials Market Analysis & Forecast to 2024-2034: Market By Product; By End-user; and By Region" report has been added to...